Protara Therapeutics, Inc. - 10-Q Filing

Protara Therapeutics reports Q3 2026 financial results including updates on equity incentive plans and debt securities composition.

SEC EDGAR ·

Tickers: $TARA

Read the full article at SEC EDGAR

More Regulatory news